Skip to main content
Clinical Trials/NL-OMON43784
NL-OMON43784
Completed
N/A

The neural substrate of cognitive and social-emotional apathy in patients with schizophrenia - The neural substrate of apathy in schizophrenia

niversitair Medisch Centrum Groningen0 sites80 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
apathy
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
80
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with schizophrenia (N\=60\)
  • \- At least 18 years of age
  • \- DSM\-IV diagnosis of schizophrenia, or schizoaffective disorder
  • \- High levels of cognitive or social\-emotional apathy
  • \- Absence or low level of apathy
  • \- Patient groups will be matched on age, sex, education, levels of depressive symptoms, levels of D2 dopamine receptor occupancy and handedness
  • \- Written informed consent;Healthy controls (N\=20\)
  • \- At least 18 years of age
  • \- Matched to patients on age, sex, education, levels of depressive symptoms and handedness
  • \- Written informed consent

Exclusion Criteria

  • Patients with schizophrenia (N\=60\)
  • Presence of a substance dependence disorder
  • Presence of a neurological disorder
  • Use of medication that can influence task results (e.g. beta\-blockers, insulin);Healthy controls (N\=20\)
  • Presence of a neurological or psychiatric disorder, in present or past.
  • Use of medication that can influence task results (e.g. psychopharmaca, beta\-blockers, insulin)
  • High levels of apathy (a score of more than 27 on the AES);All subjects (N\=80\):
  • Visual or hearing problems that cannot be corrected
  • Insufficient knowledge of the Dutch language
  • Inability to undergo cognitive testing

Outcomes

Primary Outcomes

Not specified

Similar Trials